Viewing data from:

COLISTIMETHATE SODIUM

ANDA

COLISTIMETHATE SODIUM | A205356 | XELLIA PHARMACEUTICALS APS

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$15.49

per ea

Lowest NADAC/Unit

$15.49

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
70594002309COLISTIMETHATE 150 MG VIAL	$15.49	EA	Generic	—	2026-05-20
70594002301COLISTIMETHATE 150 MG VIAL	$15.49	EA	Generic	—	2026-05-20

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$8.21

Highest Price

$329.28

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
70594-0023-01COLISTIMETHATE NA (COLISTIN BASE 150MG/VIL) I	$8.21	FSS	Golden State Medical Supply, Inc.	06/14/2028
70594-0023-04COLISTIMETHATE NA (COLISTIN BASE 150MG/VIL) I	$329.28	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

XELLIA PHARMACEUTICALS APSCOLISTIMETHATE SODIUM USP

DMF 133631998

LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTDCOLISTIMETHATE SODIUM

DMF 283502014

HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO LTDCOLISTIMETHATE SODIUM

DMF 351772020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 2, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 150MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: May 29, 2015

No patent or exclusivity listings for this strength.